» Articles » PMID: 5492246

Quantitative Measurement of Iron Stores with Diethylenetriamine Penta-acetic Acid

Overview
Journal Gut
Specialty Gastroenterology
Date 1970 Nov 1
PMID 5492246
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The use of the chelating agent diethylenetriamine penta-acetic acid (DTPA) for measuring body storage iron was investigated in patients with iron excess whose stores could be determined by venesection. Iron excretion after DTPA bore a close semi-logarithmic relationship to body iron stores when these were increased. The excretion of DTPA-bound (59)Fe was similarly related to the size of the stores, indicating that the increased iron excretion produced by DTPA in iron overload states reflects both increased tissue iron available for chelation and greater stability of the iron-chelate complex. Evidence was obtained that injected (59)Fe-DTPA could be used as a marker for chelated tissue iron enabling the DTPA-chelatable body iron pool to be calculated. There was a highly significant correlation between DTPA-chelatable iron and body storage iron. The regression intercept approximated to the origin, implying a specific relation between the DTPA effect and storage iron. The SE of the mean estimate for storage iron on DTPA-chelatable iron was 0.25 g (5.6%). Mean storage iron values of 392 mg for males and 243 mg for females were predicted from the findings in control subjects.

Citing Articles

Desferrithiocin: a search for clinically effective iron chelators.

Bergeron R, Wiegand J, McManis J, Bharti N J Med Chem. 2014; 57(22):9259-91.

PMID: 25207964 PMC: 4255733. DOI: 10.1021/jm500828f.


Liver iron concentration, stainable iron, and total body storage iron.

Barry M Gut. 1974; 15(5):411-5.

PMID: 18668853 PMC: 1412923. DOI: 10.1136/gut.15.5.411.


Measurement of iron stores in cirrhosis using diethylenetriamine penta-acetic acid.

Barry M, Cartei G, Sherlock S Gut. 1970; 11(11):899-904.

PMID: 5492247 PMC: 1553133. DOI: 10.1136/gut.11.11.899.


Relationship of hepatic iron concentration to histochemical grading and to total chelatable body iron in conditions associated with iron overload.

Walker R, Miller J, Dymock I, Shilkin K, Williams R Gut. 1971; 12(12):1011-4.

PMID: 5157130 PMC: 1411991. DOI: 10.1136/gut.12.12.1011.


Iron depletion, deficiency and overload.

POLLYCOVE M West J Med. 1986; 145(5):684-5.

PMID: 3798917 PMC: 1307126.


References
1.
Peters G, KEBERLE H, Schmid K, Brunner H . Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol. 1966; 15(1):93-109. DOI: 10.1016/0006-2952(66)90114-6. View

2.
MEYER-BRUNOT H, KEBERLE H . The metabolism of desferrioxamine B and ferrioxamine B. Biochem Pharmacol. 1967; 16(3):527-35. DOI: 10.1016/0006-2952(67)90100-1. View

3.
Balcerzak S, WESTERMAN M, Heinle E, Taylor F . Measurement of iron stores using deferoxamine. Ann Intern Med. 1968; 68(3):518-25. DOI: 10.7326/0003-4819-68-3-518. View

4.
Harker L, FUNK D, Finch C . Evaluation of storage iron by chelates. Am J Med. 1968; 45(1):105-15. DOI: 10.1016/0002-9343(68)90012-0. View

5.
FIGUEROA W, Thompson J . Biliary iron excretion in normal and iron-loaded rats after desferrioxamine and CaDTPA. Am J Physiol. 1968; 215(4):807-10. DOI: 10.1152/ajplegacy.1968.215.4.807. View